The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity
Open accessAbstract
The OX-40 receptor (OX-40R), a member of the TNFR family, is primarily expressed on activated CD4+ T lymphocytes. Engagement of the OX-40R, with either OX-40 ligand (OX-40L) or an Ab agonist, delivers a strong costimulatory signal to effector T cells. OX-40R+ T cells isolated from inflammatory lesions in the CNS of animals with experimental autoimmune encephalomyelitis are the cells that respond to autoantigen (myelin basic protein) in vivo. We identified OX-40R+ T cells within primary tumors and tumor-invaded lymph nodes of patients with cancer and hypothesized that they are the tumor-Ag-specific T cells. Therefore, we investigated whether engagement of the OX-40R in vivo during tumor priming would enhance a tumor-specific T cell response. Injection of OX-40L:Ig or anti-OX-40R in vivo during tumor priming resulted in a significant improvement in the percentage of tumor-free survivors (20–55%) in four different murine tumors derived from four separate tissues. This anti-OX-40R effect was dose dependent and accentuated tumor-specific T cell memory. The data suggest that engagement of the OX-40R in vivo augments tumor-specific priming by stimulating/expanding the natural repertoire of the host’s tumor-specific CD4+ T cells. The identification of OX-40R+ T cells clustered around human tumor cells in vivo suggests that engagement of the OX-40R may be a practical approach for expanding tumor-reactive T cells and thereby a method to improve tumor immunotherapy in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., & Nagata, S. (1992) · Nature · doi:10.1038/356314a0 · Cited by 2,885
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Shi, S. R., Key, M. E., & Kalra, K. L. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.6.1709656 · Cited by 2,552
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
Townsend, S. E., & Allison, J. P. (1993) · Science · doi:10.1126/science.7678351 · Cited by 1,136
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Chen, L., Ashe, S., Brady, W. A., Hellström, I., Hellström, K. E., Ledbetter, J. A., McGowan, P., & Linsley, P. S. (1992) · Cell · doi:10.1016/s0092-8674(05)80059-5 · Cited by 1,050
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
Melero, I., Shuford, W. W., Newby, S. A., Aruffo, A., Ledbetter, J. A., Hellström, K. E., Mittler, R. S., & Chen, L. (1997) · Nature Medicine · doi:10.1038/nm0697-682 · Cited by 898
Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.87 · Cited by 828
Shuford, W. W., Klussman, K., Tritchler, D. D., Loo, D. T., Chalupny, J., Siadak, A. W., Brown, T. J., Emswiler, J., Raecho, H., Larsen, C. P., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.47 · Cited by 804
Ox-40 Ligand: A Potent Costimulatory Molecule for Sustaining Primary CD4 T Cell Responses
Gramaglia, I., Weinberg, A. D., Lemon, M., & Croft, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6510 · Cited by 527
Self-citationMiyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S., & Taniguchi, N. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3753 · Cited by 494
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I., & Hellström, K. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.523 · Cited by 462
Zhang, X., Brunner, T., Carter, L., Dutton, R. W., Rogers, P., Bradley, L., Sato, T., Reed, J. C., Green, D., & Swain, S. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1837 · Cited by 459
PATERSON, D., JEFFERIES, W., GREEN, J., BRANDON, M., CORTHESY, P., PUKLAVEC, M., & WILLIAMS, A. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90122-2 · Cited by 447
Expression and function of OX40 ligand on human dendritic cells
Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C., & Delespesse, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.3838 · Cited by 420
A Lymphotoxin-β-Specific Receptor
Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Din, W. S., Goodwin, R. G., & Smith, C. A. (1994) · Science · doi:10.1126/science.8171323 · Cited by 396
Stüber, E., Neurath, M., Calderhead, D., Perry Fell, H., & Strober, W. (1995) · Immunity · doi:10.1016/1074-7613(95)90031-4 · Cited by 390
Hurwitz, A. A., Yu, T. F.-Y., Leach, D. R., & Allison, J. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10067 · Cited by 378
The selection and characterization of an invasive variant of the B16 melanoma.
Hart, I. R. (1979) · PubMed · Cited by 371
Flynn, S., Toellner, K.-M., Raykundalia, C., Goodall, M., & Lane, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.297 · Cited by 351
The host—tumor immune conflict: from immunosuppression to resistance and destruction
Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., & Blay, J. Y. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01115-8 · Cited by 350
Role of 4-1BB in immune responses
Vinay, D. S., & Kwon, B. S. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0157 · Cited by 312
Imura, A., Hori, T., Imada, K., Ishikawa, T., Tanaka, Y., Maeda, M., Imamura, S., & Uchiyama, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2185 · Cited by 309
Baum, P. R., Gayle, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F., Baker, E., Sutherland, G. R., & Clifford, K. N. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06715.x · Cited by 283
Ohshima, Y., Yang, L.-P., Uchiyama, T., Tanaka, Y., Baum, P., Sergerie, M., Hermann, P., & Delespesse, G. (1998) · Blood · doi:10.1182/blood.v92.9.3338 · Cited by 268
Baskar, S., Ostrand-Rosenberg, S., Nabavi, N., Nadler, L. M., Freeman, G. J., & Glimcher, L. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5687 · Cited by 263
Weinberg, A. D., Wegmann, K. W., Funatake, C., & Whitham, R. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1818 · Cited by 252
Self-citationEstablishment of mouse colonic carcinoma cell lines with different metastatic properties.
Brattain, M. G., Strobel‐Stevens, J. D., Fine, D., et al. (1980) · PubMed · Cited by 234
Maxwell, J. R., Weinberg, A., Prell, R. A., & Vella, A. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.107 · Cited by 219
Self-citationPape, K. A., Merica, R., Mondino, A., Khoruts, A., & Jenkins, M. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4719 · Cited by 193
Baskar, S., Glimcher, L., Nabavi, N., Jones, R. T., & Ostrand-Rosenberg, S. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.619 · Cited by 182
CD27: marker and mediator of T-cell activation?
Hintzen, R. Q., de Jong, R., Lens, S. M. A., & van Lier, R. W. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90077-9 · Cited by 165
Nagata, Y., Furugen, R., Hiasa, A., Ikeda, H., Ohta, N., Furukawa, K., Nakamura, H., Furukawa, K., Kanematsu, T., & Shiku, H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1336 · Cited by 156
Weinberg, A. D., BOURDETTE, D. N., Sullivan, T. J., Lemon, M., Wallin, J. J., Maziarz, R. T., Davey, M. P., Palida, F., Godfrey, W. R., Engleman, E. G., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-183 · Cited by 156
Self-citationHu, H., Urba, W. J., & Fox, B. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3033 · Cited by 153
Self-citationOX-40: life beyond the effector T cell stage
Weinberg, A. D., Vella, A. T., & Croft, M. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0146 · Cited by 149
Self-citationMiura, S., Ohtani, K., Numata, N., Niki, M., Ohbo, K., Ina, Y., Gojobori, T., Tanaka, Y., Tozawa, H., Nakamura, M., et al. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1313 · Cited by 141
Vetto, J. T., Lum, S. S., Morris, A. M., Sicotte, M., Davis, J. L., Lemon, M., & Weinberg, A. D. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00139-6 · Cited by 120
Self-citationKagamu, H., & Shu, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3444 · Cited by 103
Weinberg, A. D., Wallin, J. J., Jones, R. E., Sullivan, T. J., BOURDETTE, D. N., Vandenbark, A. A., & Offner, H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4712 · Cited by 95
Self-citationBaskar, S., Clements, V. K., Glimcher, L. H., Nabavi, N., & Ostrand‐Rosenberg, S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3821 · Cited by 69
Kaleeba, J. A. R. (1998) · International Immunology · doi:10.1093/intimm/10.4.453 · Cited by 67
Litton, M. J., Sander, B., Murphy, E., O’Garra, A., & Abrams, J. S. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90330-1 · Cited by 64
6th international congress of immunology
(1985) · Veterinary Immunology and Immunopathology · doi:10.1016/0165-2427(85)90144-8 · Cited by 58
Cited by
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
The role of TNF superfamily members in T-cell function and diseases
Croft, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2526 · Cited by 920
Metadata
- Authors
- Weinberg, A. D., Rivera, M.-M., Prell, R., Morris, A., Ramstad, T., Vetto, J. T., Urba, W. J., Alvord, G., Bunce, C., & Shields, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-02
- Volume
- 164
- Issue
- 4
- Pages
- 2160-2169
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2103767560
- Cited by
- 387
- References
- 46
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.